A pragmatic regulatory approach for complex generics through the U.S. FDA 505(j) or 505(b)(2) approval pathways - Klein - 2021 - Annals of the New York Academy of Sciences - Wiley Online Library
Provisional Translation (as of October 2021)* Administrative Notice September 14, 2021 To: Pharmaceutical Affairs Section, Prefe
How Is the Quality of a Generic Drug Evaluated?
Guideline for Bioequivalence Studies for Different Strengths of Oral Solid Dosage Forms
Study of regulatory requirements for the conduct of bioequivalence studies in US, Europe, Canada, India, ASEAN and SADC countrie
Guideline for Bioequivalence Studies of Generic Products
PDF) Implementation of Bioequivalence Studies for Approval of Generic Drug Products in Sudan: Current Status | abubakr Nur - Academia.edu
Japan | SpringerLink
ETHICAL GUIDELINES AND STUDY DESIGN FOR BIOAVAILABILITY AND BIOEQUIVALENCE STUDY | Semantic Scholar
Bioequivalence of topical generic products. Part 2. Paving the way to a tailored regulatory system - ScienceDirect
Bioavailability and Bioequivalence Studies | IntechOpen
Pharmacogenetic perspectives in improving pharmacokinetic profiles for efficient bioequivalence trials with highly variable drugs: a review | International Journal of Pharmacokinetics
Myths, questions, facts about generic drugs in the EU - GaBI Journal
Guideline for Bioequivalence Studies for Different Strengths of Oral Solid Dosage Forms